A randomized, phase 2 trial of denintuzumab mafodotin and RICE vs RICE alone in the treatment of patients (pts) with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL) who are candidates for autologous stem cell transplant (ASCT) Meeting Abstract
| Authors: | Chen, R. W.; Jacobsen, E. D.; Kostic, A.; Liu, T.; Moskowitz, C. H. |
| Abstract Title: | A randomized, phase 2 trial of denintuzumab mafodotin and RICE vs RICE alone in the treatment of patients (pts) with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL) who are candidates for autologous stem cell transplant (ASCT) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 415s |
| Language: | English |
| ACCESSION: | WOS:000404711505096 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.TPS7584 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS7584 -- Source: Wos |
